RecruitingAdrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm

Project: Every Child for Younger Patients With Cancer

Eligible age

Up to 25 yrs

Accepts

All genders

Locations

49 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Sponsor: Children's Oncology Group

You may qualify if…

✓ Enrollment must occur within 6 months of initial disease presentation OR within 6 months of refractory disease, disease progression, disease recurrence, second or secondary malignancy, or post-mortem
✓ Patients previously enrolled on ACCRN07 are eligible to enroll on Tracking Outcome, Registry and Future Contact components of APEC14B1 any time after they reach age of majority
✓ Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment as follows:
✓ All cancer cases with an International Classification of Diseases for Oncology (ICD-O) histologic behavior code of one "1" (borderline), two "2" (carcinoma in situ) or three "3" (malignant)
✓ All neoplastic lesions of the central nervous system regardless of behavior, i.e., benign, borderline or malignant
✓ All neoplastic lesions of the kidney regardless of behavior, i.e., benign, borderline or malignant
✓ The following other benign/borderline conditions:
✓ Mesoblastic nephroma